nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-Inflammatory and Neuroprotective Effects of DIPOPA (N,N-Diisopropyl-2-Oxopropanamide), an Ethyl Pyruvate Bioisoster, in the Postischemic Brain
|
Lee, Hye-Kyung |
|
2019 |
16 |
2 |
p. 523-537 |
artikel |
2 |
Anti-Inflammatory and Neuroprotective Effects of DIPOPA (N,N-Diisopropyl-2-Oxopropanamide), an Ethyl Pyruvate Bioisoster, in the Postischemic Brain
|
Lee, Hye-Kyung |
|
|
16 |
2 |
p. 523-537 |
artikel |
3 |
Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction
|
Hastings, Michelle L. |
|
2019 |
16 |
2 |
p. 348-359 |
artikel |
4 |
Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction
|
Hastings, Michelle L. |
|
|
16 |
2 |
p. 348-359 |
artikel |
5 |
Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction
|
Hastings, Michelle L. |
|
|
16 |
2 |
p. 348-359 |
artikel |
6 |
Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice
|
Griñán-Ferré, Christian |
|
|
16 |
2 |
p. 416-431 |
artikel |
7 |
Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice
|
Griñán-Ferré, Christian |
|
|
16 |
2 |
p. 416-431 |
artikel |
8 |
Comparison and Selection of Current Implantable Anti-Epileptic Devices
|
Wong, Stephen |
|
2019 |
16 |
2 |
p. 369-380 |
artikel |
9 |
Comparison and Selection of Current Implantable Anti-Epileptic Devices
|
Wong, Stephen |
|
|
16 |
2 |
p. 369-380 |
artikel |
10 |
Comparison and Selection of Current Implantable Anti-Epileptic Devices
|
Wong, Stephen |
|
|
16 |
2 |
p. 369-380 |
artikel |
11 |
Efficacy of Cilostazol Administration in Alzheimer’s Disease Patients with White Matter Lesions: A Positron-Emission Tomography Study
|
Lee, Jun-Young |
|
2019 |
16 |
2 |
p. 394-403 |
artikel |
12 |
Efficacy of Cilostazol Administration in Alzheimer’s Disease Patients with White Matter Lesions: A Positron-Emission Tomography Study
|
Lee, Jun-Young |
|
|
16 |
2 |
p. 394-403 |
artikel |
13 |
Efficacy of Cilostazol Administration in Alzheimer's Disease Patients with White Matter Lesions: A Positron-Emission Tomography Study
|
Lee, Jun-Young |
|
|
16 |
2 |
p. 394-403 |
artikel |
14 |
Endovascular Stroke Therapy
|
Smith, Wade S. |
|
2019 |
16 |
2 |
p. 360-368 |
artikel |
15 |
Endovascular Stroke Therapy
|
Smith, Wade S. |
|
|
16 |
2 |
p. 360-368 |
artikel |
16 |
Endovascular Stroke Therapy
|
Smith, Wade S. |
|
|
16 |
2 |
p. 360-368 |
artikel |
17 |
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
|
Buijsen, Ronald A.M. |
|
2018 |
16 |
2 |
p. 263-286 |
artikel |
18 |
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
|
Buijsen, Ronald A.M. |
|
|
16 |
2 |
p. 263-286 |
artikel |
19 |
Nucleic Acid–Based Therapeutics for Parkinson’s Disease
|
Nakamori, Masayuki |
|
2019 |
16 |
2 |
p. 287-298 |
artikel |
20 |
Nucleic Acid–Based Therapeutics for Parkinson’s Disease
|
Nakamori, Masayuki |
|
|
16 |
2 |
p. 287-298 |
artikel |
21 |
Nucleic Acid–Based Therapeutics for Parkinson's Disease
|
Nakamori, Masayuki |
|
|
16 |
2 |
p. 287-298 |
artikel |
22 |
Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions
|
Greenfield, Ariele L. |
|
2019 |
16 |
2 |
p. 314-318 |
artikel |
23 |
Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions
|
Greenfield, Ariele L. |
|
|
16 |
2 |
p. 314-318 |
artikel |
24 |
Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions
|
Greenfield, Ariele L. |
|
|
16 |
2 |
p. 314-318 |
artikel |
25 |
Nucleic Acid Therapeutics for Neurological Diseases
|
Watts, Jonathan K. |
|
2019 |
16 |
2 |
p. 245-247 |
artikel |
26 |
Nucleic Acid Therapeutics for Neurological Diseases
|
Watts, Jonathan K. |
|
|
16 |
2 |
p. 245-247 |
artikel |
27 |
Nucleic Acid Therapies for Ischemic Stroke
|
Henninger, Nils |
|
2019 |
16 |
2 |
p. 299-313 |
artikel |
28 |
Nucleic Acid Therapies for Ischemic Stroke
|
Henninger, Nils |
|
|
16 |
2 |
p. 299-313 |
artikel |
29 |
Nucleic Acid Vaccine Targeting Nogo-66 Receptor and Paired Immunoglobulin-Like Receptor B as an Immunotherapy Strategy for Spinal Cord Injury in Rats
|
Lu, Xiu-Min |
|
2019 |
16 |
2 |
p. 381-393 |
artikel |
30 |
Nucleic Acid Vaccine Targeting Nogo-66 Receptor and Paired Immunoglobulin-Like Receptor B as an Immunotherapy Strategy for Spinal Cord Injury in Rats
|
Lu, Xiu-Min |
|
|
16 |
2 |
p. 381-393 |
artikel |
31 |
Nucleic Acid Vaccine Targeting Nogo-66 Receptor and Paired Immunoglobulin-Like Receptor B as an Immunotherapy Strategy for Spinal Cord Injury in Rats
|
Lu, Xiu-Min |
|
|
16 |
2 |
p. 381-393 |
artikel |
32 |
Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
|
Krichevsky, Anna M. |
|
2019 |
16 |
2 |
p. 319-347 |
artikel |
33 |
Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
|
Krichevsky, Anna M. |
|
|
16 |
2 |
p. 319-347 |
artikel |
34 |
Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich’s Ataxia Mouse Model
|
Mollá, Belén |
|
2019 |
16 |
2 |
p. 432-449 |
artikel |
35 |
Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich’s Ataxia Mouse Model
|
Mollá, Belén |
|
|
16 |
2 |
p. 432-449 |
artikel |
36 |
Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model
|
Mollá, Belén |
|
|
16 |
2 |
p. 432-449 |
artikel |
37 |
Plasma Periostin and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
|
Kanamaru, Hideki |
|
2019 |
16 |
2 |
p. 480-490 |
artikel |
38 |
Plasma Periostin and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
|
Kanamaru, Hideki |
|
|
16 |
2 |
p. 480-490 |
artikel |
39 |
Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
|
Francardo, Veronica |
|
2019 |
16 |
2 |
p. 465-479 |
artikel |
40 |
Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease
|
Francardo, Veronica |
|
|
16 |
2 |
p. 465-479 |
artikel |
41 |
Prostaglandin A1 Inhibits the Cognitive Decline of APP/PS1 Transgenic Mice via PPARγ/ABCA1-dependent Cholesterol Efflux Mechanisms
|
Xu, Guo-Biao |
|
2019 |
16 |
2 |
p. 505-522 |
artikel |
42 |
Prostaglandin A1 Inhibits the Cognitive Decline of APP/PS1 Transgenic Mice via PPARγ/ABCA1-dependent Cholesterol Efflux Mechanisms
|
Xu, Guo-Biao |
|
|
16 |
2 |
p. 505-522 |
artikel |
43 |
Prostaglandin A1 Inhibits the Cognitive Decline of APP/PS1 Transgenic Mice via PPARγ/ABCA1-dependent Cholesterol Efflux Mechanisms
|
Xu, Guo-Biao |
|
|
16 |
2 |
p. 505-522 |
artikel |
44 |
Spatial Training Ameliorates Long-Term Alzheimer’s Disease-Like Pathological Deficits by Reducing NLRP3 Inflammasomes in PR5 Mice
|
Ren, Qing-Guo |
|
|
16 |
2 |
p. 450-464 |
artikel |
45 |
Spatial Training Ameliorates Long-Term Alzheimer's Disease-Like Pathological Deficits by Reducing NLRP3 Inflammasomes in PR5 Mice
|
Ren, Qing-Guo |
|
|
16 |
2 |
p. 450-464 |
artikel |
46 |
Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat Diseases
|
Zain, Rula |
|
2019 |
16 |
2 |
p. 248-262 |
artikel |
47 |
Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat Diseases
|
Zain, Rula |
|
|
16 |
2 |
p. 248-262 |
artikel |
48 |
TET1 Overexpression Mitigates Neuropathic Pain Through Rescuing the Expression of μ-Opioid Receptor and Kv1.2 in the Primary Sensory Neurons
|
Wu, Qiang |
|
|
16 |
2 |
p. 491-504 |
artikel |
49 |
TET1 Overexpression Mitigates Neuropathic Pain Through Rescuing the Expression of μ-Opioid Receptor and Kv1.2 in the Primary Sensory Neurons
|
Wu, Qiang |
|
|
16 |
2 |
p. 491-504 |
artikel |
50 |
Venlafaxine Mitigates Depressive-Like Behavior in Ovariectomized Rats by Activating the EPO/EPOR/JAK2 Signaling Pathway and Increasing the Serum Estradiol Level
|
Saad, Muhammed A. |
|
2018 |
16 |
2 |
p. 404-415 |
artikel |
51 |
Venlafaxine Mitigates Depressive-Like Behavior in Ovariectomized Rats by Activating the EPO/EPOR/JAK2 Signaling Pathway and Increasing the Serum Estradiol Level
|
Saad, Muhammed A. |
|
|
16 |
2 |
p. 404-415 |
artikel |